Tess Ely
Impact in
- Oncology top 5%
- Peptidase Inhibition and Analysis
- Molecular Biology top 10%
- Protein Kinase Regulation and GTPase Signaling
- Melanoma and MAPK Pathways
- PI3K/AKT/mTOR signaling in cancer
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
Papers in
- Oncology 1
- Peptidase Inhibition and Analysis 1
-
- Protein Kinase Regulation and GTPase Signaling 2
- Ubiquitin and proteasome pathways 1
- Co-authors
- Ulf Peters (1 shared paper)Linda V. Kessler (1 shared paper)Matthew Robert Janes (1 shared paper)Rasmus Hansen (1 shared paper)Jeffrey H. Chen (1 shared paper)Pingda Ren (1 shared paper)Jun Li Feng (1 shared paper)Matthew P. Patricelli (1 shared paper)
- Partner nations
- BelgiumUnited States
In The Last Decade
Tess Ely
2 papers receiving 1.5k citations
Tess Ely's Hit Papers
Peers
Comparison fields: 5 of 62
- Oncology 546
- Molecular Biology 1.2k
- Cancer Research 137
- Cell Biology 120
- Pulmonary and Respiratory Medicine 195
Countries citing papers authored by Tess Ely
This map shows the geographic impact of Tess Ely's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tess Ely with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tess Ely more than expected).
Fields of papers citing papers by Tess Ely
This network shows the impact of papers produced by Tess Ely. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tess Ely. The network helps show where Tess Ely may publish in the future.
Co-authors
The 14 scholars most cited alongside Tess Ely, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor Hit paper breakdown → | 2018 | 928 |
| 2 | Selective Inhibition of Oncogenic KRAS Output with Small Molecules Targeting the Inactive State Hit paper breakdown → | 2016 | 616 |
About Tess Ely
Tess Ely is a scholar working on Oncology, Molecular Biology, Insect Science, Renewable Energy, Sustainability and the Environment and Obstetrics and Gynecology, having authored 2 papers that have together received 1.5k indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (2 papers), Ubiquitin and proteasome pathways (1 paper) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Oncology (546 citations), Molecular Biology (1.2k citations), Cancer Research (137 citations), Cell Biology (120 citations) and Pulmonary and Respiratory Medicine (195 citations). Tess Ely has collaborated with scholars based in Belgium and United States. Frequent co-authors include Ulf Peters, Linda V. Kessler, Matthew Robert Janes, Rasmus Hansen, Jeffrey H. Chen, Pingda Ren, Jun Li Feng, Matthew P. Patricelli, Sarah J. Firdaus and Yi Sha Liu. Their work appears in journals such as Cell and Cancer Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.